Synthesis 2024; 56(06): 989-998
DOI: 10.1055/a-2181-9709
paper
Emerging Trends in Glycoscience

Efficient Synthesis of Natural Product Inspired Naphthoquinone-Fused Glycohybrids and Their In Silico Docking Studies

Ashish Khanna
a   Department of Chemistry, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, 221005, India
,
Ghanshyam Tiwari
a   Department of Chemistry, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, 221005, India
,
Vinay Kumar Mishra
a   Department of Chemistry, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, 221005, India
,
Kavita Singh
b   Glycochemistry Laboratory, School of Physical Sciences, Jawaharlal Nehru University, New Delhi, 110067, India
,
Ram Sagar
a   Department of Chemistry, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, 221005, India
b   Glycochemistry Laboratory, School of Physical Sciences, Jawaharlal Nehru University, New Delhi, 110067, India
› Author Affiliations
A.K. and G.T. are grateful to Banaras Hindu University for research fellowships. V.K.M. and K.S. are thankful to the University Grants Commission (UGC) New Delhi for research fellowships (SRF/JRF).


Abstract

Naphthoquinones, a diverse group of natural compounds with a 1,4-naphthoquinone core structure, have gained attention for their pharmacological properties. The anticancer activity of these compounds is attributed to their ability to accept electrons, leading to the generation of reactive oxygen species that cause DNA damage and cell death. In recent studies, hydroxy-1,4-naphthoquinone derivatives, including daunorubicin, have shown promising inhibitory effects against several human cancers, such as acute myeloid leukemia, chronic myelogenous leukemia, and Kaposi’s sarcoma. To further explore their potential as anticancer agents, this research article focuses on the design and synthesis of natural product inspired naphthoquinone-based glycohybrids. These glycohybrids are designed based on the structures of bioactive aryl glycosides and quinones, aiming to enhance their binding affinity and specificity towards cancer-related protein targets. The interactions between the synthesized glycohybrids and target proteins through computational docking simulations has been studied and better binding affinity was found.

Supporting Information



Publication History

Received: 10 August 2023

Accepted after revision: 26 September 2023

Accepted Manuscript online:
26 September 2023

Article published online:
07 November 2023

© 2023. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Son EJ, Kim JH, Kim K, Park CB. J. Mater. Chem. A 2016; 4: 11179
  • 2 El-Najjar N, Gali-Muhtasib H, Ketola RA, Vuorela P, Urtti A, Vuorela H. Phytochem. Rev. 2011; 10: 353
  • 3 Badart MP, Hawkins BC. Synthesis 2021; 53: 1683
  • 4 Allen JF, Martin W. Nature 2007; 445: 610
  • 5 Imran M, Rauf A, Khan IA, Shahbaz M, Qaisrani TB, Fatmawati S, Abu-Izneid T, Imran A, Rahman KU, Gondal TA. Biomed. Pharmacother. 2018; 106: 390
  • 6 Kayashima T, Mori M, Yoshida H, Mizushina Y, Matsubara K. Cancer Lett. 2009; 278: 34
  • 7 Aminin D, Polonik S. Chem. Pharm. Bull. 2020; 68: 46
  • 8 Paengsri W, Lee VS, Chong WL, Wahab HA, Baramee A. Int. J. Biol. Chem. 2012; 6: 69
  • 9 Lamson DW, Plaza SM. Altern. Med. Rev. 2003; 8: 303
  • 10 Liu H, Yan C, Li C, You T, She Z. Molecules 2020; 25: 576
  • 11 Pereyra CE, Dantas RF, Ferreira SB, Gomes LP, Silva-Jr FP. Cancer Cell Int. 2019; 19: 207
  • 12 Bililign T, Griffith BR, Thorson JS. Nat. Prod. Rep. 2005; 22: 742
  • 13 Toshima K, Ouchi H, Okazki Y, Kano T, Moriguchi M, Asai A, Matsumura S. Angew. Chem., Int. Ed. Engl. 1997; 36: 2748
  • 14 Postema MH. D. Tetrahedron 1992; 48: 8545
  • 15 Hacksell U, Daves GD. Prog. Med. Chem. 1985; 22: 1
  • 16 García-Herrero A, Montero E, Muñoz JL, Espinosa JF, Vián A, García JL, Asensio JL, Cañada FJ, Jiménez-Barbero J. J. Am. Chem. Soc. 2002; 124: 4804
  • 17 Ravishankar R, Surolia A, Vijayan M, Lim S, Kishi Y. J. Am. Chem. Soc. 1998; 120: 11297
  • 18 Faul MM, Huff BE. Chem. Rev. 2000; 100: 2407
  • 19 Gudmundsson KS, Drach JC, Townsend LB. J. Org. Chem. 1997; 62: 3453
  • 20 Townsend LB, Devivar RV, Turk SR, Nassiri MR, Drach JC. J. Med. Chem. 1995; 38: 4098
  • 21 Rohr J, Thiericke R. Nat. Prod. Rep. 1992; 9: 103
  • 22 Kharel MK, Pahari P, Shepherd MD, Tibrewal N, Nybo SE, Shaaban KA, Rohr J. Nat. Prod. Rep. 2012; 29: 264
  • 23 Heapy AM, Patterson AV, Smaill JB, Jamieson SM. F, Guise CP, Sperry J, Hume PA, Rathwell K, Brimble MA. Bioorg. Med. Chem. 2013; 21: 7971
  • 24 Zhang Y, Ye Q, Wang X, She Q, Thorson JS. Angew. Chem. Int. Ed. 2015; 54: 11219
  • 25 Tomaszkiewicz-Potępa A, Vogt O. Wiad. Chem. 2004; 58: 881
  • 26 Sartori G, Bigi F, Canali G, Maggi R, Casnati G, Tao X. J. Org. Chem. 1993; 58: 840
  • 27 Aronov AM, Clain BM, Moody CS, Murcko MA. J. Med. Chem. 2008; 51: 1214
  • 28 Nicolaou KC. Angew. Chem. Int. Ed. 2014; 53: 9128
  • 29 Chakraborty S, Das G, Ghosh S, Mal D. Org. Biomol. Chem. 2016; 14: 10636
  • 30 Yang C.-W, Peng T.-T, Hsu H.-Y, Lee Y.-Z, Wu S.-H, Lin W.-H, Ke Y.-Y, Hsu T.-A, Yeh T.-K, Huang W.-Z, Lin J.-H, Sytwu H.-K, Chen C.-T, Lee S.-J. Biomed. J. 2020; 43: 368
  • 31 Nicholas SD, Smith F. Nature 1948; 161: 349
  • 32 Negi AS, Chattopadhyay SK, Srivastava S, Bhattacharya AK. Synth. Commun. 2005; 35: 15
  • 33 Ramesh N, Balasubramanian KK. Tetrahedron Lett. 1991; 32: 3875
  • 34 Mahmoud IS, Hatmal MM, Abuarqoub D, Esawi E, Zalloum H, Wehaibi S, Nsairat H, Alshaer W. ACS Omega 2021; 6: 25299
  • 35 Patra MC, Shah M, Choi S. Semin. Cancer Biol. 2020; 64: 61